Navigation Links
Z Trim Holdings Reports Sales Growth in July 2013 over July 2012

MUNDELEIN, Ill., Aug. 1, 2013 /PRNewswire/ -- Z Trim Holdings, Inc. (OTC Markets: ZTHO – News), a bio-technology company providing value-added ingredients to a variety of industries, today announced that it recorded, for the month of July 2013, sales growth of 20% over the month of July 2012.

"We continue to gain acceptance with new customers," said Lynda Carroll, VP of Sales and Applications. "This was apparent at the IFT show in Chicago this July. Not only did we have over 2,000 people sample our sausages made with Z Trim at our booth, but a customer of ours showed samples of chicken nuggets made with Z Trim at their booth."


Z Trim Holdings, Inc. ( is a bio-technology company that owns existing, and has developed new, products and processes to make use of biomass for uses in the food and industrial markets.  The Company's food division currently sells a line of products to the food industry that can help food manufacturers reduce their costs and help them solve many production problems.  The Company's revolutionary technology provides value-added ingredients across virtually all food industry categories.  The Company's all-natural products, among other things, help to reduce fat and calories, add fiber, provide shelf-stability, prevent oil migration, and add binding capacity – all without degrading the taste and texture of the final food products.  Perhaps most significantly, Z Trim's products can help extend finished products, and thereby increase its customers' gross margins.  The Company's industrial division, opened in 2012, sells eco-friendly ingredients to oil drilling, hydraulic fracturing, petroleum coke, steel/aluminum, paper and other industries.  The Company's industrial ingredients are highly functional in applications for adhesives, binders, viscofiers and emulsifiers.

Forward-Looking Statements and Risk Factors

Certain statements in this press release are "forward−looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of Z Trim Holdings to be materially different from any future results, performance or achievements expressed or implied by these forward−looking statements. Other factors, which could materially affect such forward−looking statements, can be found in our filings with the Securities and Exchange Commission at, including risk factors relating to our history of operating losses, that our auditors have expressed substantial doubt regarding our ability to continue as a going concern, the fact that we may dilute existing shareholders through additional stock issuances, and our reliance on our intellectual property. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward−looking statements and are cautioned not to place undue reliance on such forward−looking statements. The forward−looking statements made herein are only made as of the date of this press release and we undertake no obligation to publicly update such forward−looking statements to reflect subsequent events or circumstances.Contacts:Media:

Investor Relations:Angela Strickland

Thomas Wagner (847) 549-6002

Legend Securities,

718-233-2627 Twitter

John ColumbiaFacebook

Legend Securities, Inc.LinkedIn


SOURCE Z Trim Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
2. Hadasit Bio-Holdings Ltd. to Present at the Third Annual Connecticut-Israel Technology Summit
3. Z Trim Holdings Reports Continued Sales Growth in May 2013
4. Pacific Shore Holdings Retains Investor Relations Firm
5. Hadasit Bio-Holdings CEO Letter to Shareholders
6. Medical Marijuana Inc., Corporate Update- Significant Revenue and Net Income Growth 1st Quarter- Division and Corporate Holdings Update
7. Z Trim Holdings Announces Conclusion of Successful Warrant Exercise Program: Raises $2.195 Million
8. Z Trim Holdings Reports Sales Growth in February 2013
9. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
10. Green Dot Holdings LLC Acquires MGP’s Bioplastics Division
11. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
Post Your Comments:
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... business and prospects remain fundamentally strong and highlights ... doxorubicin) recently received DSMB recommendation to continue the ... review of the final interim efficacy and safety ... Endpoint in men with heavily pretreated castration- and ...
(Date:11/24/2015)... KUALA LUMPUR, Malaysia , Nov. 24, 2015 ... the global contract research organisation (CRO) market. The ... to result in lower margins but higher volume ... With increased capacity and scale, however, margins in ... Contract Research Organisation (CRO) Market ( ...
(Date:11/24/2015)... Worcester, Mass. (PRWEB) , ... November 24, 2015 ... ... need to maintain healthy metabolism. But unless it is bound to proteins, copper ... Institutes of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a ...
Breaking Biology Technology:
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):